Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab
RSL3 联合治疗可使铁死亡和 EGFR 抑制耐药的 HNSCC 对西妥昔单抗产生敏感性
期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms23169014
Shujie Liu, Shuai Yan, Jie Zhu, Ruiqing Lu, Chujie Kang, Kang Tang, Jinfeng Zeng, Mingmei Ding, Zixiang Guo, Xianxin Lai, Yinan Jiang, Siqing Wu, Lihua Zhou, Litao Sun, Zhong-Wei Zhou